Extracorporeal Membrane Oxygenation Machine Market Analysis and Forecast by 2032
The global Extracorporeal Membrane Oxygenation Machine Market was worth $531 million in 2021 and is predicted to rise at a steady CAGR of 5% from 2022 to 2032, reaching a valuation of US$ 908 million by the end of 2032.
Recent developments in
extracorporeal membrane oxygenation systems market innovations
such as miniaturization of ECMO components like hollow pumps, which are used in
various surgeries, aids in the transportation of critically ill patients,
thereby increasing the ECOM
systems market size.
As per the ECOM systems market study, the rising use of
ECMO has sparked technological advancements in extracorporeal membrane oxygenation machines of which
oxygenators and heparin-coated cannulas are two major emerging trends in the ECOM systems market.
The study finds that extracorporeal membrane oxygenation devices are used in
life-threatening situations when other forms of supportive care have failed.
Furthermore, the use of ECMO in various healthcare settings has increased
significantly owing to its wide range of applications.
The adoption of ECMO procedures
is being promoted by several government organizations. One of them is GOLD
(Global Initiative for Chronic Obstructive Lung Disease), a campaign that aims
to raise awareness about COPD and its treatment, which includes the use
of ECMO oxygen machine thereby
positively influencing the ECMO
systems adoption trends.
The sudden spike in COVID-19 cases, combined with an
increase in the number of critically ill patients requiring additional life
support, has pushed up demand for
ECMO machines. For patients with severe acute respiratory distress
syndrome, extracorporeal membrane
oxygenation therapy has been the preferred treatment option.
An increasing number of supportive government policies and
the rapid FDA approval of extracorporeal
membrane oxygenation equipment for emergency use have significantly
increased the ECOM systems market
opportunities.
Competitive Landscape: Companies
like Medtronic plc (U.S.), Fresenius Medical care A.G. & Co. KGAA
(Germany), Getinge Group (Sweden), Microport (China), Origin
Biomedical (U.S.), Terumo Cardiovascular Systems Corporation, Livanova plc
(U.K.), Nipro Corporation (Japan), Euro sets S.R.L. (Italy), Cytosorbents
Corporation (Australia), and Abiomed. dominate the global market.
Browse More@ https://www.futuremarketinsights.com/reports/extracorporeal-membrane-oxygenation-machine-market
Key Segments
By Product:
- ECMO
Machines
- Portable
Devices
- Static
Devices
- Software
By Service Type:
- Application
- Middleware
- Infrastructure
By Component:
- Pumps
- Oxygenators
- Controllers
- Cannul
- Assessories
By Modality:
- Veno-Venous
- Veno-Arterials
- Arterio-Venous
By Patient Type:
- Neonates
- Pediatrics
- Adults
Comments
Post a Comment